InvestorsHub Logo
Followers 30
Posts 2208
Boards Moderated 0
Alias Born 12/13/2016

Re: nidan7500 post# 141353

Friday, 02/16/2018 3:29:22 PM

Friday, February 16, 2018 3:29:22 PM

Post# of 463642
Nidan, what you are saying is that Anavex has added advanced target acquisition capability to 2-73. And the FDA may see it shortly as the best weapon against Alzheimer's and a host of other high priority CNS disease targets. Sounds like the #1 drug for the ACTC to adopt and develop full support for. We are in a target rich environment....lets launch!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News